News

Video

Envision Summit 2025: Eradicating TRD

At the Envision Summit 2025 in San Juan, Puerto Rico, Kristen Nwanyanwu, MD, MBA, MHS, joined by her children, discussed her talk on eradicating TRD and the family-friendly environment of the conference.

At the Envision Summit 2025 in San Juan, Puerto Rico, Kristen Nwanyanwu, MD, MBA, MHS, joined by her children, discussed her talk on eradicating TRD and the family-friendly environment of the conference.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

Kristen Nwanyanwu, MD, MBA, MHS:

Hello. I'm Kristen Nwanyanwu, associate professor of ophthalmology and visual science at Yale University. My talk was "Eradicate TRD," and what we're really trying to figure out is how to address challenges in access to care, particularly in humans that have advanced diabetic retinopathy to prevent blindness. So we talked about research. So our scene lab where we look at community engagement and big data and implementation science and try to figure out options to help advance care and people that really need it. We talked about advocacy and the work that the Academy is doing, and the American Society of Retinal Specialists trying to figure out how to get access to the care that we need. And we talked about incentives and talking about appropriate incentives for people that may not have access to sight-saving care that we can provide.

Of course, we love the Envision conference. We love the fact that the kids can come and they can see the talks. We love the fact that it's right next to the scientific meeting, so you can come across and they have a great time. What did you think, girls, about it? I thought it was wonderful. Yeah. How about you? It's awesome. Would you come back? Yes, all right. Great

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.